Clincosm LogoSign in Get a demo

Glioblastoma Multiforme

Showing NaN - NaN of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)

Not yet recruiting
  • High Grade Glioma
  • +8 more
  • Aurora, Colorado
  • +17 more
May 2, 2023

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Glioblastoma Multiforme Trial in United States (Keto Diet, Usual Diet)

    Not yet recruiting
    • Glioblastoma Multiforme
    • Keto Diet
    • Usual Diet
    • Los Angeles, California
    • +4 more
    Jan 31, 2023

    Glioblastoma Multiforme Trial in Australia, United States (Nivolumab, Temozolomide)

    Active, not recruiting
    • Glioblastoma Multiforme
    • Durham, North Carolina
    • +19 more
    Jul 14, 2022

    Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

    Recruiting
    • Glioblastoma
    • +11 more
    • San Francisco, California
    • +11 more
    Jul 13, 2022

    Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed

    Completed
    Has Results
    • Glioblastoma
    • +3 more
    • Unpulsed DCs
    • +6 more
    • Durham, North Carolina
      Duke University Medical Center
    Jan 3, 2022

    Glioblastoma Multiforme, Glioblastoma, Malignant Glioma Trial in Gainesville, Orlando, Durham (pp65-shLAMP DC with GM-CSF,

    Recruiting
    • Glioblastoma Multiforme
    • +4 more
    • pp65-shLAMP DC with GM-CSF
    • +4 more
    • Gainesville, Florida
    • +2 more
    Jan 6, 2022

    Glioblastoma, Grade IV Astrocytoma, Glioblastoma Multiforme Trial in United States (MDNA55)

    Completed
    • Glioblastoma
    • +3 more
    • San Francisco, California
    • +6 more
    Jan 13, 2021

    Glioblastoma Multiforme Trial in Israel, United States (VB-111, Bevacizumab)

    Completed
    • Glioblastoma Multiforme
    • Boston, Massachusetts
    • +3 more
    Apr 23, 2020

    Glioblastoma Multiforme Trial in United States (Cilengitide 500 mg, Cilengitide 2000 mg)

    Completed
    Has Results
    • Glioblastoma Multiforme
    • Cilengitide 500 mg
    • Cilengitide 2000 mg
    • Birmingham, Alabama
    • +16 more
    Jan 18, 2019

    Glioblastoma Multiforme, Gliosarcoma Trial in Durham (Gliadel, Radiation Therapy, Avastin)

    Terminated
    Has Results
    • Glioblastoma Multiforme
    • Gliosarcoma
    • Durham, North Carolina
      The Preston Robert Tisch Brain Tumor Center
    Jan 30, 2019

    Glioblastoma Multiforme, Gliosarcoma Trial in Durham (AMG 102, Avastin)

    Completed
    Has Results
    • Glioblastoma Multiforme
    • Gliosarcoma
    • Durham, North Carolina
      The Preston Robert Tisch Brain Tumor Center
    Dec 9, 2015

    Glioblastoma Multiforme, GBM, Gliosarcoma Trial in Canada, United States (AR-67

    Unknown status
    • Glioblastoma Multiforme
    • +2 more
    • AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin)
    • Chicago, Illinois
    • +8 more
    Dec 8, 2014

    Glioblastoma Multiforme Trial in United States (XL184)

    Completed
    • Glioblastoma Multiforme
    • Los Angeles, California
    • +7 more
    Jul 15, 2014

    Glioblastoma Multiforme, Anaplastic Glioma Trial in Durham (Temodar and O6-Benzylguanine (BG))

    Completed
    • Glioblastoma Multiforme
    • Anaplastic Glioma
    • Temodar and O6-Benzylguanine (BG)
    • Durham, North Carolina
      Duke University Health System
    Jul 8, 2014

    Glioblastoma Multiforme, Gliosarcoma Trial in Durham (Avastin, Temozolomide, Irinotecan)

    Completed
    Has Results
    • Glioblastoma Multiforme
    • Gliosarcoma
    • Durham, North Carolina
      The Preston Robert Tisch Brain Tumor Center at Duke University M
    Feb 5, 2014

    Glioblastoma Multiforme Trial in Durham (Bevacizumab, Metronomic Temozolomide)

    Completed
    Has Results
    • Glioblastoma Multiforme
    • Durham, North Carolina
      Duke University Medical Center (Brain Tumor Center)
    May 17, 2013

    Malignant Glioma, Glioblastoma Multiforme, Gliosarcoma Trial in Durham (Gliadel/Avastin/CPT-11)

    Terminated
    Has Results
    • Malignant Glioma
    • +2 more
    • Durham, North Carolina
      Duke University Medical Center
    Feb 4, 2013

    Glioblastoma Multiforme, Gliosarcoma, Anaplastic Astrocytoma Trial in Durham (enzyme-inducing anti-epileptic drugs)

    Withdrawn
    • Glioblastoma Multiforme
    • +4 more
    • enzyme-inducing anti-epileptic drugs
    • Durham, North Carolina
      Duke University Medical Center
    Nov 20, 2012

    Glioblastoma Multiforme Trial in United States (Everolimus, Surgery)

    Terminated
    Has Results
    • Glioblastoma Multiforme
    • Los Angeles, California
    • +7 more
    Sep 20, 2011

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma Trial in United States (IL13-PE38QQR, Surgery for placement,

    Completed
    • Glioblastoma Multiforme
    • +2 more
    • San Francisco, California
    • +5 more
    Jun 30, 2011

    Glioblastoma Multiforme Trial in Worldwide (IL13-PE38QQR, surgery and catheter placement (2 procedures), prolifespan 20 with

    Completed
    • Glioblastoma Multiforme
    • Birmingham, Alabama
    • +59 more
    Jun 2, 2011

    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Durham (IL13-PE38QQR, targeted fusion protein

    Completed
    • Malignant Glioma
    • +4 more
    • Durham, North Carolina
      Duke University Medical Center
    Jun 2, 2011

    Glioblastoma Multiforme Trial in United States (CT-322, Temozolomide, Radiation Therapy)

    Unknown status
    • Glioblastoma Multiforme
    • Little Rock, Arkansas
    • +5 more
    Oct 26, 2010

    Glioblastoma Multiforme Trial in Canada, United States (TLN-4601)

    Terminated
    • Glioblastoma Multiforme
    • New York, New York
    • +7 more
    Dec 29, 2009